MinhTri Nguyen, MD's Avatar

MinhTri Nguyen, MD

@minhtrimd.bsky.social

Medical Oncologist at Stanford | Certified Coach | Researcher in emotional intelligence | Always learning, and finding good food. My opinions are my own. #Medsky #Oncosky

425 Followers  |  731 Following  |  23 Posts  |  Joined: 12.11.2024  |  2.0878

Latest posts by minhtrimd.bsky.social on Bluesky

Preview
Primum A digital platform helping patients receive better care closer to home. We connect oncologists with sub-specialists to discuss their most complex cancer cases.

Sometimes Oncology just doesn’t follow guidelines. I use Primum when I hit those moments. Thoughtful, fast answers from peers who know their stuff. If you're curious:

Great for fellows and those already in practice.

24.04.2025 17:24 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Post image

Is surgery always necessary for invasive breast cancer? πŸ©ΊπŸ”
New research is challenging the status quo and exploring less invasive paths for treatment. A must-read for oncology professionals.

Read more: ascopost.com/news/april-2...
#BreastCancer #CancerResearch #ASCO2025

07.04.2025 14:01 β€” πŸ‘ 0    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0

No generational judgementβ€”disheartening to see burnout at all. Especially in
In a field that clearly still holds joy for those that practice. The landscape is not what it used to be & we’ve trained to be nimble with medical decisionβ€”not staffing, prior auth, or EMR burden.

30.01.2025 06:20 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Post image

The FDA has approved trastuzumab deruxtecan (T-DXd) for patients with HR-positive, HER2-low, or HER2-ultralow metastatic breast cancer based on DESTINY-Breast06 trial results. #BreastCancer #Oncology ascopost.com/news/january...

28.01.2025 17:58 β€” πŸ‘ 5    πŸ” 2    πŸ’¬ 0    πŸ“Œ 1

Your continued support in me is so humbling Dr Abraham. I’m very grateful for you. Thank you.

17.01.2025 15:27 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Preview
MinhTri Nguyen, MD on LinkedIn: From strawberries to stethoscopes: lessons in humanity from a future… Thank you to Kevin Pho, M.D. for publishing my story. And Kim Downey for encouraging me to submit my personal statement β€œas is”. As I continue to practice in…

Thank you for sharing your incredible immigrant story from Vietnam - to selling strawberries on the streets of Maine - one of our best fellows at @clevelandclinic.bsky.social and now as an oncologist in @Stanford medicine www.linkedin.com/posts/minhtr...
@minhtrimd.bsky.social inspiring!

17.01.2025 12:19 β€” πŸ‘ 2    πŸ” 1    πŸ’¬ 1    πŸ“Œ 0
Post image

I was born in the mountains of πŸ‡»πŸ‡³. At 5 my parents sought the land of opportunity πŸ‡ΊπŸ‡Έ. This Dec our family reunited in πŸ‡»πŸ‡³. My country has changed and so have we. Change = opportunity.

From my Fam to yours: Happy new years! With the change, I hope you also find your opportunities to grow.

29.12.2024 08:25 β€” πŸ‘ 3    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0

Thank you Dr Abraham!

23.12.2024 23:10 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Post image

A bit late on the announcement but thrilled to be selected for the Stanford Physician Leadership Certificate Program! I look forward to learning and enhancing my leadership skills and leadership theory.

I accept! (-ed before the deadline) :)

#leadership

22.12.2024 17:13 β€” πŸ‘ 2    πŸ” 0    πŸ’¬ 1    πŸ“Œ 0
Kaplan–Meier estimates of progression-free survival among all 426 patients in the imlunestrant–abemaciclib and imlunestrant groups who had undergone randomization concurrently.

Kaplan–Meier estimates of progression-free survival among all 426 patients in the imlunestrant–abemaciclib and imlunestrant groups who had undergone randomization concurrently.

The selective estrogen-receptor degrader imlunestrant plus abemaciclib led to a median progression-free survival of 9.4 months among patients with ER-positive, HER2-negative breast cancer (vs. 5.5 months with imlunestrant alone). Full EMBER-3 trial results: nej.md/4fZ74HX

#MedSky #SABCS24

11.12.2024 14:08 β€” πŸ‘ 29    πŸ” 7    πŸ’¬ 0    πŸ“Œ 3
Primum A digital platform helping patients receive better care closer to home. We connect oncologists with sub-specialists to discuss their most complex cancer cases.

I’ve found many apps to be extremely useful as a fellow and practicing oncologist.

For a quick (usually less than 48 hrs) curbside consult to an Oncologist, Hematologist, RadOnc, Pharmacist etc. I’ve been using Primum. You can also ask anonymously. See link.
#oncsky #cansky #medsky

12.12.2024 16:01 β€” πŸ‘ 2    πŸ” 0    πŸ’¬ 1    πŸ“Œ 0

We have known for decade+ that you can detect progression using ctDNA months before you see it on scans. But until we show that it impacts outcomes to change tx earlier all it does is make ppl anxious and abandon treatments (TKIs) that may still be helping. Most MRD use today is marketing over data.

08.12.2024 13:06 β€” πŸ‘ 35    πŸ” 14    πŸ’¬ 4    πŸ“Œ 1

Wrote this haiku before #ASHaiku for #ASH24 but I’d like to shamelessly repost for submission. In response to @oligoclonalband.bsky.social β€˜s cooly made Neuro-skirt.

02.12.2024 22:35 β€” πŸ‘ 6    πŸ” 0    πŸ’¬ 2    πŸ“Œ 0

Cool pic! Now be expecting a billion β€œwhere/what is this” comments. I didn’t get to see this exhibit…I’m overdue for another trip to Japan it seems!

02.12.2024 22:27 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Post image Post image Post image Post image

Day 2 of #BLADDR24
Dr Rob Jones
Case metastatic UCa
Treatment sequencing in the era of combination therapies

Emphasizes that first-line therapy with EV and P is poised to become the new SoC

@drnataliagandur.bsky.social
@barbaramelao.bsky.social
@yukselurun.bsky.social
@achoud72.bsky.social

28.11.2024 10:56 β€” πŸ‘ 8    πŸ” 4    πŸ’¬ 0    πŸ“Œ 0
Preview
James Stoller, MD & MinhTri Nguyen, MD - Developing Leaders in Healthcare - Phronesis: Practical Wisdom for Leaders with Scott Allen Dr. Stoller is Chairman of the Education Institute at Cleveland Clinic. He holds the Jean Wall Bennett Professorship of Medicine at Cleveland Clinic Lerner College of Medicine and the Samson Global Le...

My interview on developing leaders in healthcare with James Stoller, MD and Scott Allen, Ph.D.

#leadership #medsky

23.11.2024 16:56 β€” πŸ‘ 5    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0

Team labs Borderless or planets. Won’t regret it.

23.11.2024 07:10 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 1    πŸ“Œ 1

@valdesan.bsky.social to the rescue! Oncology Vol 1 and 2 starter packs (links included in the packs)

go.bsky.app/UP8aWPd

#medsky #oncsky #oncosky #oncology

23.11.2024 07:06 β€” πŸ‘ 6    πŸ” 3    πŸ’¬ 0    πŸ“Œ 0

@valdesan.bsky.social May have answered my prayers.

Starter pack (vol 2) here go.bsky.app/UP8aWPd. Vol 1 also on his account!

23.11.2024 07:01 β€” πŸ‘ 3    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Preview
Administration of Trastuzumab Deruxtecan in Metastatic Breast Cancer Patients with Severe Hepatic Impairment Trastuzumab deruxtecan (T-DXd) shows efficacy in HER2-positive and HER2-low metastatic breast cancer (MBC), but its safety in patients with hepatic im…

Interesting case series (n=3) from Emory of patients with pretreated HER2+ and HER2-low MBC with severe hepatic impairment tolerating well and deriving clinical benefit from dose-reduced T-DXd. www.sciencedirect.com/science/arti...

23.11.2024 01:19 β€” πŸ‘ 6    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0

This is true. RBCs are super cute. I’ll entertain.

22.11.2024 05:55 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0

Blood on my dress pants
Is not the best look for me
Hematology

#medsky #oncosky a #poem

21.11.2024 06:46 β€” πŸ‘ 3    πŸ” 0    πŸ’¬ 1    πŸ“Œ 1

I do want everyone to know that I actually DID start a list... So please if you find that helpful I can share (or can you find it?). (and yes, I did stop working on it because I did get hungry). To be continued. Maybe. #oncosky #oncology #WhereAreMyFriends

19.11.2024 01:53 β€” πŸ‘ 3    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0

Amazing. Imagine the next level: Incorporating such large language models into our EMR systems to provide suggested matched clinical trials in real time! These LLM are already being trialed and implemented for inbox management at some institutions. Anxiously hopeful. πŸ™

19.11.2024 01:49 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0

You know, I started a list... and then I got hungry. 🫠

19.11.2024 01:44 β€” πŸ‘ 3    πŸ” 0    πŸ’¬ 1    πŸ“Œ 0
Post image 19.11.2024 01:42 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0

Specifically oncology and hematology? Please say more!

18.11.2024 18:33 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0

Can we get one of those nifty β€œclick to follow all of these profiles” for #oncosky #cansky?

I’m thinking someone must being working on this…right? Or did I just volunteer myself? 😭
πŸ‘‰πŸ‘ƒ

#medsky

18.11.2024 07:06 β€” πŸ‘ 19    πŸ” 2    πŸ’¬ 4    πŸ“Œ 1

Oh my.

18.11.2024 03:09 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0

It’s getting a little hairy over there πŸ‘€β€¦Time to find bluer skies.

πŸ¦‹

#medsky #oncosky

17.11.2024 19:47 β€” πŸ‘ 11    πŸ” 0    πŸ’¬ 1    πŸ“Œ 0

@minhtrimd is following 20 prominent accounts